Erratum: Novel Areas for Prevention and Control of Canine Leishmaniosis: (Trends in Parasitology 33, 718–730; 2017) (S1471492217301289) (10.1016/j.pt.2017.05.005))

Guadalupe Miró; Christine Petersen; Luís Cardoso; Patrick Bourdeau; Gad Baneth; Laia Solano-Gallego; Maria Grazia Pennisi; Lluís Ferrer; Gaetano Oliva

doi:10.1016/j.pt.2017.11.003

Erratum: Novel Areas for Prevention and Control of Canine Leishmaniosis: (Trends in Parasitology 33, 718–730; 2017) (S1471492217301289) (10.1016/j.pt.2017.05.005))

Guadalupe Miró, Christine Petersen, Luís Cardoso, Patrick Bourdeau, Gad Baneth, Laia Solano-Gallego, Maria Grazia Pennisi, Lluís Ferrer, Gaetano Oliva

Department of Animal Medicine and Surgery

Research output: Other contribution

4 Citations (Scopus)

Abstract

The authors of this Review wish to issue the following correction: Table 3 in our recent paper contained incorrect details regarding the administration of paromomycin. In this table, administration of paromomycin is indicated to be oral (PO), however, as described in the literature, this antibiotic has been employed for canine leishmaniosis therapy exclusively by the subcutaneous (SC) route. In addition, it is well known that all aminoglycoside drugs have a limited intestinal absorption, with no efficacy on systemic diseases when employed PO.

Original language	English
Number of pages	1
Edition	5
Volume	34
DOIs	https://doi.org/10.1016/j.pt.2017.11.003
Publication status	Published - May 2018

Publication series

Name	Trends in Parasitology
Publisher	Cell Press
ISSN (Print)	1471-4922

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/j.pt.2017.11.003Licence: Other

Cite this

@misc{f73fc46523bc4f91b8c56652541b8327,

title = "Erratum: Novel Areas for Prevention and Control of Canine Leishmaniosis: (Trends in Parasitology 33, 718–730; 2017) (S1471492217301289) (10.1016/j.pt.2017.05.005))",

abstract = "The authors of this Review wish to issue the following correction: Table 3 in our recent paper contained incorrect details regarding the administration of paromomycin. In this table, administration of paromomycin is indicated to be oral (PO), however, as described in the literature, this antibiotic has been employed for canine leishmaniosis therapy exclusively by the subcutaneous (SC) route. In addition, it is well known that all aminoglycoside drugs have a limited intestinal absorption, with no efficacy on systemic diseases when employed PO.",

author = "Guadalupe Mir{\'o} and Christine Petersen and Lu{\'i}s Cardoso and Patrick Bourdeau and Gad Baneth and Laia Solano-Gallego and Pennisi, \{Maria Grazia\} and Llu{\'i}s Ferrer and Gaetano Oliva",

note = "Publisher Copyright: {\textcopyright} 2017 Elsevier Ltd",

year = "2018",

month = may,

doi = "10.1016/j.pt.2017.11.003",

language = "English",

volume = "34",

series = "Trends in Parasitology",

publisher = "Cell Press",

edition = "5",

type = "Other",

}

TY - GEN

T1 - Erratum

T2 - Novel Areas for Prevention and Control of Canine Leishmaniosis: (Trends in Parasitology 33, 718–730; 2017) (S1471492217301289) (10.1016/j.pt.2017.05.005))

AU - Miró, Guadalupe

AU - Petersen, Christine

AU - Cardoso, Luís

AU - Bourdeau, Patrick

AU - Baneth, Gad

AU - Solano-Gallego, Laia

AU - Pennisi, Maria Grazia

AU - Ferrer, Lluís

AU - Oliva, Gaetano

PY - 2018/5

Y1 - 2018/5

N2 - The authors of this Review wish to issue the following correction: Table 3 in our recent paper contained incorrect details regarding the administration of paromomycin. In this table, administration of paromomycin is indicated to be oral (PO), however, as described in the literature, this antibiotic has been employed for canine leishmaniosis therapy exclusively by the subcutaneous (SC) route. In addition, it is well known that all aminoglycoside drugs have a limited intestinal absorption, with no efficacy on systemic diseases when employed PO.

AB - The authors of this Review wish to issue the following correction: Table 3 in our recent paper contained incorrect details regarding the administration of paromomycin. In this table, administration of paromomycin is indicated to be oral (PO), however, as described in the literature, this antibiotic has been employed for canine leishmaniosis therapy exclusively by the subcutaneous (SC) route. In addition, it is well known that all aminoglycoside drugs have a limited intestinal absorption, with no efficacy on systemic diseases when employed PO.

UR - https://www.scopus.com/pages/publications/85034850826

U2 - 10.1016/j.pt.2017.11.003

DO - 10.1016/j.pt.2017.11.003

M3 - Other contribution

C2 - 29174223

AN - SCOPUS:85034850826

VL - 34

T3 - Trends in Parasitology

ER -

Erratum: Novel Areas for Prevention and Control of Canine Leishmaniosis: (Trends in Parasitology 33, 718–730; 2017) (S1471492217301289) (10.1016/j.pt.2017.05.005))

Abstract

Publication series

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this